Veeva Systems (NYSE:VEEV - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 7.630-7.630 for the period, compared to the consensus earnings per share estimate of 7.560. The company issued revenue guidance of $3.1 billion-$3.1 billion, compared to the consensus revenue estimate of $3.1 billion. Veeva Systems also updated its FY 2026 guidance to 7.630-7.630 EPS.
Wall Street Analysts Forecast Growth
VEEV has been the topic of several research analyst reports. Stifel Nicolaus raised their price objective on shares of Veeva Systems from $272.00 to $295.00 and gave the stock a "buy" rating in a research note on Thursday. Morgan Stanley raised their price objective on shares of Veeva Systems from $201.00 to $210.00 and gave the stock an "underweight" rating in a research note on Thursday. Raymond James raised their price objective on shares of Veeva Systems from $285.00 to $310.00 and gave the stock an "outperform" rating in a research note on Thursday. Wells Fargo & Company raised their price objective on shares of Veeva Systems from $285.00 to $300.00 and gave the stock an "overweight" rating in a research note on Thursday. Finally, Citigroup raised their price objective on shares of Veeva Systems from $265.00 to $329.00 and gave the stock a "buy" rating in a research note on Friday. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, Veeva Systems presently has a consensus rating of "Moderate Buy" and an average price target of $269.00.
View Our Latest Report on VEEV
Veeva Systems Stock Performance
Shares of NYSE:VEEV traded up $0.99 on Friday, hitting $280.03. The stock had a trading volume of 3,578,987 shares, compared to its average volume of 1,147,282. Veeva Systems has a twelve month low of $170.25 and a twelve month high of $285.70. The firm's 50 day moving average price is $229.69 and its 200-day moving average price is $227.56. The company has a market capitalization of $45.56 billion, a price-to-earnings ratio of 69.14, a price-to-earnings-growth ratio of 1.89 and a beta of 0.96.
Veeva Systems (NYSE:VEEV - Get Free Report) last issued its earnings results on Wednesday, May 28th. The technology company reported $1.97 EPS for the quarter, beating the consensus estimate of $1.74 by $0.23. Veeva Systems had a net margin of 25.07% and a return on equity of 13.56%. The company had revenue of $759.04 million for the quarter, compared to the consensus estimate of $728.38 million. During the same quarter in the previous year, the company earned $1.50 EPS. The firm's revenue for the quarter was up 16.7% compared to the same quarter last year. As a group, sell-side analysts predict that Veeva Systems will post 4.35 EPS for the current year.
Insider Activity
In related news, Director Timothy S. Cabral sold 3,882 shares of Veeva Systems stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $216.83, for a total value of $841,734.06. Following the completion of the transaction, the director now directly owns 5,500 shares of the company's stock, valued at $1,192,565. The trade was a 41.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jonathan Faddis sold 787 shares of Veeva Systems stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $226.20, for a total value of $178,019.40. Following the completion of the transaction, the senior vice president now directly owns 8,668 shares of the company's stock, valued at $1,960,701.60. This represents a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,869 shares of company stock worth $1,284,917. Corporate insiders own 10.30% of the company's stock.
Veeva Systems Company Profile
(
Get Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading

Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.